The company is to release its Q4 report on the earnings day on February 23, 2023. Vanguard Group has increased its stake in the company by 3.60%. Dynavax Technologies Corp. is a biopharmaceutical c...
Tag: Biopharmaceutical
F-star Surges 60% On $161 Mln Acquisition Offer By Chinese Billionaire Family’s Sino Biopharmaceutical
Gains in economic development and income have turned China into one of the world’s largest markets … [+] for pharmaceuticals and spawned home-grown industry heavyweights. (Photo by Kevin F...
Late-Stage Biopharmaceutical Sierra Oncology announces acquisition by GSK
Sierra Oncology (NASDAQ: SRRA) shares traded significantly higher after announcing the acquisition by GlaxoSmithKline PLC (LON: GSK) for $55 a share in cash. That represents a total equity value of $1...